• 1
    Parfitt AM, 1990 Bone-forming cells in clinical conditions. In: HallBK, (ed.) Bone: A Treatise, Vol 1, The Osteoblast and Osteocyte. Telford Press, Caldwell, NJ, U.S.A., pp. 351429.
  • 2
    Parfitt AM, 1996 Skeletal heterogeneity and the purposes of bone remodeling: implications for the understanding of osteoporosis. In: MarcusR, FeldmanD, KelseyJ, (eds.) Osteoporosis. Academic Press, San Diego, CA, U.S.A., pp. 315329.
  • 3
    Parfitt AM, Villanueva AR, Foldes J, Rao DS 1995 Relations between histologic indices of bone formation: Implications for the pathogenesis of spinal osteoporosis J Bone Miner Res 10:466473.
  • 4
    Parfitt AM, 1997 Vitamin D and the pathogenesis of rickets and osteomalacia. In: FeldmanD, GlorieuxF, PikeW, (eds.) Vitamin D. Academic Press, San Diego, CA, U.S.A., pp. 645662.
  • 5
    Han Z-H, Palnitkar S, Roa D Sudhaker, Nelson D, Parfitt AM 1996 Effect of ethnicity and age or menopause on the structure and geometry of iliac bone J Bone Miner Res 11:19671975.
  • 6
    Han Z-H, Palnitkar S, Rao DS, Nelson D, Parfitt AM 1997 Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: Implications for mechanisms of bone loss J Bone Miner Res 12:498508.
  • 7
    Nelson D, Kleerekoper M, Pawluszka A, Kirk C, Siegel D, Jacobsen G, Peterson E 1993 Recruitment of older African-American and white women for a longitudinal study of skeletal health J Women's Health 2:359366.
  • 8
    Kleerekoper M, Nelson DA, Peterson EL, Flynn MJ, Pawluszka AS, Jacobsen G, Wilson P 1994 Reference data for bone mass, calciotropic hormones, and biochemical markers of bone remodeling in older (55–75) postmenopausal white and black women J Bone Miner Res 9:12671276.
  • 9
    Foldes J, Parfitt AM, Shih M-S, Rao DS, Kleerekoper M 1991 Structural and geometric changes in iliac bone: Relationship to normal aging and osteoporosis J Bone Miner Res 6:759766.
  • 10
    Parfitt AM, Foldes J, Villanueva AR, Shih MS 1991 The difference in label length between demethylchlortetracycline and oxytetracycline: Implications for the interpretation of bone histomorphometry Calcif Tissue Int 48:744777.
  • 11
    Rao DS, 1983 Practical approach to bone biopsy. In: ReckerR, (ed.) Bone Histomorphometry: Techniques and Interpretations. CRC Press, Boca Raton, FL, U.S.A., pp. 311.
  • 12
    Parfitt AM, Podenphant J, Villanueva AR, Frame B 1985 Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: A bone histomorphometric study Bone 6:211220.
  • 13
    Mathews CHE, Mehr L 1979 Staining and processing bone specimens for simultaneous tetracycline-osteoid seam assessment and bone histomorphometric quantitative analysis J Histotechnol 2:2324.
  • 14
    Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee J Bone Miner Res 2:595610.
  • 15
    Foldes J, Shih M-S, Parfitt AM 1990 Frequency distributions of tetracycline based measurements: Implications for the interpretation of bone formation indices in the absence of double labelled surfaces J Bone Miner Res 5:10631067.
  • 16
    Villanueva AR, Kujawa M, Mathews CHE, Parfitt AM 1983 Identification of the mineralization front: Comparison of a modified toluidine blue stain with tetracycline fluorescence Metab Bone Dis Rel Res 5:4145.
  • 17
    Parfitt AM, 1989 Surface specific bone remodeling in health and disease. In: KleerekoperM, KraneS, (eds.) Clinical Disorders of Bone and Mineral Metabolism. Mary Ann Liebert Publishers, Inc., New York, NY, U.S.A., pp. 714.
  • 18
    Parfitt AM, 1992 The physiologic and pathogenetic significance of bone histomorphometric data. In: CoeFL, FavusMJ, (eds.) Disorders of Bone and Mineral Metabolism. Raven Press, New York, NY, U.S.A., pp. 475489.
  • 19
    Sokal RR, Rohlf FJ, 1981 Biometry: The Principles and Practices of Statistics in Biological Research, 2nd Ed. W.H. Freeman, San Francisco, CA, U.S.A.
  • 20
    Altman DG, 1991 Practical Statistics for Medical Research. Chapman and Hall, London, U.K.
  • 21
    Ott SM 1993 Bone formation periods studied with triple tetracycline labels in women with postmenopausal osteoporosis J Bone Miner Res 8:443450.
  • 22
    Schwartz MP, Recker RR 1982 The label escape error: Determination of the active bone-forming surface in histologic sections of bone measured by tetracycline double labels Metab Bone Dis Rel Res 4:237241.
  • 23
    Kimmel DB, Recker RR, Gallagher JC, Vaswani AS, Aloia JF 1990 A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects Bone Miner 11:217235.
  • 24
    Hattner RS, Ilnicki LP, Hodge HC The dose-response relationship of tetracycline to the detectability of labeled osteons by fluorescence microscopy. In: NormanAW, SchaeferK, CoburnJW, DeLucaHF, FraserD, GrifoleitHG, HerrathDV, (eds.) Vitamin D, Biochemical, Chemical, and Clinical Aspects Related to Calcium Metabolism. DeGruyter, New York, NY, U.S.A., pp. 377380.
  • 25
    Mawer EB, Arlot ME, Reeve J, Green JR, Dattani J, Edouard C, Meunier PJ 1991 The relationship between serum vitamin D concentrations and in vivo tetracycline labeling of osteoid in crush fracture osteoporosis Calcif Tissue Int 48:7881.
  • 26
    Parfitt AM, Villanueva AR, Mathews CHE, Aswani JA, 1981 Kinetics of matrix and mineral apposition in osteoporosis and renal osteodystrophy. Relationship to rate of turnover and to cell morphology. In: JeeWSS, ParfittAM, (eds.) Bone Histomorphometry: Third International Workshop. Armour-Montagu, Paris, France, pp. 213219.
  • 27
    Keshawarz NM, Recker RR 1986 The label escape error: Comparison of measured and theoretical fraction of total bone-trabecular surface covered by single label in normals and patients with osteoporosis Bone 7:8387.
  • 28
    Martin RB 1989 Label escape theory revisited: The effects of resting periods and section thickness Bone 10:255264.
  • 29
    Frost HM, 1983 Bone histomorphometry: Correction of the “labeling escape error.” In: ReckerRR, (ed.) Bone histomorphometry: Techniques and Interpretation. CRC Press, Boca Raton, FL, U.S.A., pp. 133142.
  • 30
    Frost HM 1969 Tetracycline-based histological analysis of bone remodeling Calcif Tissue Res 3:211237.
  • 31
    Parisien M, Cosman F, Morgan D, Schnitzer M, Liang X, Nieves J, Forese L, Luckey M, Meier D, Shen V, Lindsay R, Dempster DW 1997 Histomorphometric assessment of bone mass, structure, and remodeling: A comparison between healthy black and white premenopausal women J Bone Miner Res 12:948957.
  • 32
    Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J 1985 Evidence for alteration of the vitamin D-endocrine system in blacks J Clin Invest 76:470473.
  • 33
    Reeve J, Arlot M, Wootton R, Edouard C, Tellez M, Hesp R, Green JR, Meunier PJ 1988 Skeletal blood flow, iliac histomorphometry, and strontium kinetics in osteoporosis: A relationship between blood flow and corrected apposition rate J Clin Endocrinol Metab 66:11241131.